PubMed ·

Heart failure may promote breast cancer progression through a Col10a1-associated Tgf-β/Smad-EMT pathway.

Danfeng Zhang, Man Wang, LiHua Wu, Bo Gao, Yongbiao Ai, Ziyang Wang, Ming Xu and Fengmei Yang

Published
Source
PubMed
Original
Read it at PubMed
Topics
Cardiology

In brief

Heart Failure's Hidden Role in Breast Cancer

This paper sheds light on a specific gene, Col10a1, that may act as a bridge between heart failure and breast cancer. By exploring this connection, the authors provide a foundation for future research that could lead to novel therapeutic strategies.

What they found: The study identified Col10a1 as a key player in the interaction between heart failure and breast cancer progression. It was found that patients with cardiovascular disease had higher levels of Col10a1, which correlated with accelerated tumor growth in mouse models. Additionally, knocking down Col10a1 significantly reduced aggressive cancer traits in vitro.

AI-written summary, not medical advice. Check anything you rely on against the original paper.

From the abstract

Heart failure (HF) is clinically associated with aggravated breast cancer (BC) progression; however, the integrative genomic mechanisms underlying this cardio-oncological crosstalk remain poorly understood.

The opening of the authors’ abstract. The rest is with PubMed.

Read the full abstract at PubMed

Read it on ReadSearch

Each opens after you create an account, and brings you back to this paper.

Already a reader? Sign in

All new papers in Cardiology

Get the few papers worth your time in Cardiology every morning.

ReadSearch reads the new papers in your field each day and brings you the few worth reading, each with its key finding in a sentence.

Papers belong to their authors and publishers; every page here links to the original. All research topics